Product
Salbutamol
Aliases
Salbutamol HFA-134a, Salbutamol HFA-152a
29 clinical trials
37 indications
Indication
AsthmaIndication
UrolithiasisIndication
Airway ObstructionIndication
Airway RemodelingIndication
Autonomic Nervous System DiseasesIndication
TTNIndication
Respiratory FailureIndication
Walking CapacityIndication
Amyotrophic lateral sclerosisIndication
DyspneaIndication
Asthma in ChildrenIndication
Salbutamol Adverse ReactionIndication
Lung DiseasesIndication
Cystic FibrosisIndication
HyperkalemiaIndication
mechanical ventilationIndication
Chronic Obstructive Pulmonary DiseaseIndication
WheezingIndication
IgE-mediated Abdominal PainIndication
Cardiometabolic DiseasesIndication
MyopathyIndication
Neuromuscular DisordersIndication
Musculoskeletal DisordersIndication
Nemaline MyopathyIndication
Centronuclear MyopathyIndication
Myosin Storage MyopathyIndication
One-lung VentilationIndication
Ozone Air PollutionIndication
HealthyIndication
Healthy ParticipantsIndication
BronchiectasisIndication
Primary Ciliary DyskinesiaIndication
Primary Immune DeficiencyIndication
Bronchiolitis ObliteransClinical trial
A Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Long-term Safety of Salbutamol Rescue Medication When Administered Via Metered Dose Inhalers Containing the Propellant HFA-152a or Reference HFA-134aStatus: Not yet recruiting, Estimated PCD: 2025-04-25
Clinical trial
A Phase 4, Open-label, Single Arm, 24-week, Study to Evaluate the Safety and Efficacy of Mepolizumab 100 mg SC Administered Every 4 Weeks in Indian Participants Aged ≥18 Years With Severe Eosinophilic asthMa (PRISM)Status: Recruiting, Estimated PCD: 2023-11-24
Clinical trial
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic InflammationStatus: Completed, Estimated PCD: 2022-09-07
Clinical trial
A Single Dose Two-way Cross-over Study in Healthy Participants to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers Containing Propellants HFA-152a and HFA-134aStatus: Completed, Estimated PCD: 2023-05-21
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of SAR443765 in Healthy Adult Participants and of a Single Dose of SAR443765 in Participants With Mild-to-moderate AsthmaStatus: Completed, Estimated PCD: 2023-02-24
Clinical trial
Comparative Efficacy of Nebulized Salbutamol in Alleviating Acute Renal Colic Pain: A Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Comparison of Parasympathetic Activity in Mild, Moderate, and Severe Asthma With Fixed Airway ObstructionStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase 1, Randomized, 2-part, 7-way Cross-over (Part 1) and 7-way Cross-over (Part 2), Active Device Blinded, Single Dose Study in Mild Asthmatics Aged 18-65 to Assess the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers Containing Propellants HFA-152a (Test) and HFA-134a (Reference) Via Methacholine Bronchoprovocation and Systemic Pharmacodynamic EffectsStatus: Not yet recruiting, Estimated PCD: 2024-10-15
Clinical trial
a Multicentre, Double-blind, Randomized, Placebo-controlled Phase III Trial of the Inhaled β2-adrenergic Receptor Agonist Salbutamol for Transient Tachypnoea of the Newborn (the REFSAL Trial)Status: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
Effect of Salbutamol on Walking Capacity in Ambulatory ALS PatientsStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
The Effect of Adding Nebulized Epinephrine in Asthma Exacerbation Management in Pediatric Age Group Compared to Standard of Care: Superiority TrialStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Double-blind Placebo-controlled Crossover Study to Assess the Effects of Bronchodilation on Dyspnea, Ventilatory Responses, and Exercise Tolerance in Adults With Cystic FibrosisStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
InSaKa Trial: Insulin Dextrose Infusion Versus Nebulized Salbutamol Versus Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia: a Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2025-12-20
Clinical trial
Efficacy of Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With Acute Exacerbation Chronic Obstructive Pulmonary Disease: a Randomized Clinical TrialStatus: Completed, Estimated PCD: 2017-09-30
Clinical trial
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic AntagonistsStatus: Active (not recruiting), Estimated PCD: 2022-07-30
Clinical trial
Video Assisted Study of Salbutamol Response in Viral WheezingStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing TonsillectomyStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Double-blind Randomized Controlled Trial of Inhaled Salbutamol vs Placebo for the Treatment of Acute Abdominal Pain From Food-induced IgE-mediated ReactionsStatus: Recruiting, Estimated PCD: 2024-12-25
Clinical trial
Deciphering the Molecular and Secretory Functions of a Novel and Unique Brown Adipose Tissue Depot in WomenStatus: Not yet recruiting, Estimated PCD: 2025-08-31
Clinical trial
COMPIS- Congenital Myopathy Intervention Study. An Open-label, Cross Over, Randomised, Controlled Study Using Oral SalbutamolStatus: , Estimated PCD: 2025-12-31
Clinical trial
Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung VentilationStatus: Recruiting, Estimated PCD: 2025-04-21
Clinical trial
Examining the Effect of Salbutamol Use in Asthma and/or Exercise Induced Bronchoconstriction Whilst Exercising in Ozone Air PollutionStatus: Recruiting, Estimated PCD: 2023-08-31
Clinical trial
Salbutamol Reversal of Methacholine Induced Bronchoconstriction: Vibrating Mesh Nebulizer Versus Pressurized Metered Dose InhalerStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Cardiovascular Consequences of Prolonged Inhaled Short-acting Beta-agonist Use in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase 1, Randomized, Open-label, Single Dose, 2-treatment Arm (200 μg and 800 μg), 4-way Crossover Study in Healthy Participants Aged 18 to 55 to Compare the Pharmacokinetics of Salbutamol Administered Via Metered Dose Inhalers Containing Propellants HFA-152A (Test) and HFA-134A (Reference)Status: Not yet recruiting, Estimated PCD: 2024-09-13
Clinical trial
Study on Dose-response to Bronchodilator Then Bronchodilator Dose-finding Using the Flow Interruption Technique in Children Aged 2.5 TO 6 YearsStatus: Completed, Estimated PCD: 2014-01-01
Clinical trial
Evaluating Bronchodilator Response in Patients With BronchiectasisStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
A Multicentre, Randomised, Open-Label, Parallel-Group, Phase IIIb Study to Assess the Potential for Tezepelumab-treated Patients With Severe Asthma to Reduce Background Therapy While Sustaining Asthma Control and Clinical RemissionStatus: Not yet recruiting, Estimated PCD: 2027-06-30
Clinical trial
CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in AsthmaStatus: Active (not recruiting), Estimated PCD: 2025-05-01